# Paul Austin

> Paul Austin is a Series A investor backing Biopharma and Therapeutics. See 1 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: Angel Investor
- Total investments: 1
- Last investment: Nov 2023
- Lead investor: 100%
- Last updated: Aug 2026

Paul Austin is a Series A investor focused on Biopharma and Therapeutics. Paul Austin served as Managing Director of hedge Fund Strategies at BlueArc Capital.

## Contacts

5 contacts available for Paul Austin: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/paul-austin-5699?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biopharma | 1 | 100% |
| Therapeutics | 1 | 100% |
| Biotechnology | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| AmacaThera | AmacaThera is a clinical-stage company based in Toronto. AmacaThera is redefining how therapeutics are delivered. AmacaThera has developed a platform hydrogel technology that addresses the critical problem of sustaining therapeutic delivery of pharmacological agents for multiple disease areas. AmacaThera’s lead product addresses post-operative painand consequently may have an impact on the opioid crisis. | $2.9M | Series A | Nov 28, 2023 |  |

1 of 1 investments shown.

## Co-investors
- [Lumira Ventures](https://shizune.co/investors/profile/lumira-ventures) — VC Fund, 2 deals together
- [BDC Capital’s Women in Technology Venture Fund](https://shizune.co/investors/profile/bdc-capital-s-women-in-technology-venture-fund) — VC Fund, 1 deal together
- [Inveready](https://shizune.co/investors/profile/inveready-technology-investment-group) — VC Fund, 1 deal together
- [MaRS Investment Accelerator Fund](https://shizune.co/investors/profile/mars-investment-accelerator-fund) — VC Fund, 1 deal together
- [StandUp Ventures](https://shizune.co/investors/profile/standup-ventures-i) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [BDC Venture Capital](https://shizune.co/investors/profile/bdc-venture-capital) — VC Fund
- [Real Ventures](https://shizune.co/investors/profile/real-ventures) — VC Fund
- [Anges Quebec](https://shizune.co/investors/profile/anges-quebec) — VC Fund

## Featured in investor lists
- [Biotechnology Angel Investors in Canada](https://shizune.co/investors/biotechnology-angel-investors-canada)
- [Biotech Angel Investors in Canada](https://shizune.co/investors/biotech-angel-investors-canada)

## FAQ

### What does Paul Austin invest in?

Paul Austin invests primarily in Biopharma, Therapeutics and Biotechnology startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Paul Austin?

For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Paul Austin last invest?

The most recent investment recorded for Paul Austin closed in Nov 2023. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co